Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors				Phase II, Phase I				UCSF-04458 NCT00227617
	Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors				Phase II, Phase I				CTCT 06-11 NCT00493883
	Lithium for Low-Grade Neuroendocrine Tumors				Phase II				CO07203 NIH R21CA117117-01A2, NCT00501540
	Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma				Phase II				2006-0954 NCT00607113
	Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)				Phase II				07-162 NCT00610129
	The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors				Phase II				CPTK787/ZK222584 NCT00627198
	Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors				Phase I				NCI-07-C-0047 NCI-P6880, NCT00436735
	Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors				Phase I				MAYO-MC0414 MC0414, NCT00655655

| | | | | | | |

A Service of the National Cancer Institute